Skip to content

Diagnosis and Treatment of Urinary Tract Infection Using DNA Polymerase Chain Reaction Versus Urine Culture

Diagnosis and Treatment of Urinary Tract Infection Using DNA PCR Versus Urine Culture - A Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06808451
Enrollment
136
Registered
2025-02-05
Start date
2025-10-22
Completion date
2026-09-30
Last updated
2026-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Tract Infections

Keywords

urine culture, DNA PCR

Brief summary

Adults 18 years or older with urinary tract infection (UTI) symptoms. Participants will be assigned to either the urine culture group or the DNA PCR study group by randomization. At time of enrollment in the study they will be also asked to fill out two questionnaires. If prescribed antibiotics for treatment of a UTI, participants will then be called the day after they are scheduled to stop their antibiotics. Participants will be asked to fill out questionnaires the day after finishing antibiotics. Participants will be enrolled in the study for a maximum of 21 days.

Interventions

DEVICEDNA PCR

Gene analysis with PCR will be conducted from the urine samples of the patients with acute UTI symptoms.

DIAGNOSTIC_TESTUrine Culture

Urine samples of the patients with acute UTI symptoms will be sent to the UH lab for routine urine culture.

Sponsors

University Hospitals Cleveland Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult men and women 18 years and older * Presenting to clinic with symptoms of UTI or cystitis * Patients with Medicare and Medicaid insurance

Exclusion criteria

* Urinary diversion of any type * Chronic indwelling urinary catheter * Diagnosed UTI within the previous 21 days * Antibiotic therapy within the previous 21 days * Use of phenazopyridine within the previous 21 days * Commercial insurance * Non-English speaking * Pregnant patients

Design outcomes

Primary

MeasureTime frameDescription
Change in symptoms as measured by the UTI Symptom Assessment questionnaireBaseline, one day after antibiotic completionThe UTI Symptom Assessment questionnaire is a ten item questionnaire that asks about symptom relief, with lower scores indicating less symptoms.
Change in symptoms as measured by UTI-SIQ-8 questionnaireBaseline, one day after antibiotic completionThe UTI-SIQ-8 is an eight item questionnaire that asks about symptom severity and symptom impairment on a likert scale from 0 to 4, 0 being not at all and 4 being very strong/very severe.

Secondary

MeasureTime frameDescription
Number of hospitalizations related to UTI as measured by medical record reviewUp to 21 days
Length of time from patient presentation to initiation of treatment as measured by medical record reviewUp to 21 days
Number of antibiotic changes as measured by medical record reviewUp to 21 days
Number of times participant represents with UTI symptoms as measured by medical record reviewUp to 30 daysDuration will be measured in days
Duration of antibiotic use as measured by medical record reviewUp to 21 daysDuration will be measured in days
Number of additional diagnostic procedures related to initial presenting symptoms as measured by medical record reviewUp to 21 days

Countries

United States

Contacts

CONTACTDiana N Mitchell, MD, MBA, BSN
diana.mitchell@uhhospitals.org216-844-1000
PRINCIPAL_INVESTIGATORDavid Sheyn, MD

University Hospitals

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 12, 2026